Worse Clinical Outcomes of Atrial Fibrillation in Patients with HFpEF Compared to HFrEF
A multinational prospective cohort study performed by Barak Zafrir et al. and…
Atrial Fibrillation in a Cancer Setting: Understanding Unmet Needs in Cardio-Oncology
A new study by Neal et al. demonstrated that although patients with…
Anticoagulant and Antiplatelet Therapy in Stented Patients with Atrial Fibrillation
In an article published in the Journal of the American College of…
Apple Watch Series 4 Receives FDA Approval as a Class II Medical Device
The Apple watch series 4 received FDA approval as a class II…
Can TTR levels Determine Long-term Prognosis in AFib Patients on Vitamin K Antagonists?
Findings from a Danish nationwide registry conducted among patients with Atrial Fibrillation…
Antithrombotic therapy post TAVR: A double edged sword?
A multicenter, prospective nation-wide French registry evaluated whether oral anticoagulation therapy was…
Catheter Ablation vs Medical Therapy for Atrial Fibrillation
The CABANA trial has demonstrated that catheter ablation is not superior to…
Temporary Neurotoxin Treatment to Prevent Postop AFib
Dr. C. Michael Gibson discusses the trial findings with Dr. Nathan Waldron…
Remote Heart Rhythm Sampling to screen for AFib
Dr. Julian Halcox and Dr. Rim Halaby Discuss
Oral Anticoagulants in Atrial Fibrillation
Dr. Christopher Granger and Dr. Renato Lopes discuss
Apixaban vs conventional therapy in patients with AFib undergoing cardioversion
Dr. Michael Ezekowitz and Dr. C. Michael Gibson Discuss
Effect of Bivalirudin Versus UFH in Patients with AFib in TAVR
Dr. Usman Baber and Dr. C. Michael Gibson Discuss
Digoxin in AFib With and Without Heart Failure
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss